Clinical Trial Update: This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial to determine a safe dose of Xentuzumab in combination with Abemaciclib, with or without hormonal therapies, in patients with solid tumors includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)
• Xentuzumab (Xentuzumab)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Neoplasms, Breast Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2025-06-24